We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Sigma Lithium
SGML
$1.05B
| $143K | ﹤0.01% |
10,819
-87,756
| -89% | -$756K |
|
|
GGN
2527
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$762M
| $143K | ﹤0.01% |
+27,622
| New | +$139K |
|
2528
PolyPid
PYPD
$78.2M
| $142K | ﹤0.01% |
32,661
+10,888
| +50% | +$40.4K |
|
2529
Rayonier Advanced Materials
RYAM
$562M
| $141K | ﹤0.01% |
23,963
-2,429
| -9% | -$15.8K |
|
2530
SuperCom
SPCB
$64.6M
| $141K | ﹤0.01% |
+15,584
| New | +$155K |
|
2531
Solana Company
HSDT
$96.3M
| $140K | ﹤0.01% |
+48,364
| New | +$319K |
|
2532
Sundial Growers
SNDL
$312M
| $139K | ﹤0.01% |
83,988
+62,758
| +296% | +$126K |
|
|
CLYM
2533
Climb Bio
CLYM
$693M
| $139K | ﹤0.01% |
34,852
+5,668
| +19% | +$13.6K |
|
|
CANG
2534
Cango Inc
CANG
$64M
| $139K | ﹤0.01% |
+9,293
| New | +$255K |
|
2535
Conduent
CNDT
$253M
| $139K | ﹤0.01% |
72,515
-235,993
| -76% | -$517K |
|
|
BLNE
2536
Beeline Holdings
BLNE
$31.1M
| $137K | ﹤0.01% |
+79,914
| New | +$194K |
|
|
TCGL
2537
DELISTED
TechCreate Group Ltd
TCGL
| $137K | ﹤0.01% |
+26,375
| New | +$137K |
|
|
RCS
2538
PIMCO Strategic Income Fund
RCS
$242M
| $137K | ﹤0.01% |
+24,576
| New | +$171K |
|
|
BGX
2539
Blackstone Long-Short Credit Income Fund
BGX
$135M
| $137K | ﹤0.01% |
+11,729
| New | +$138K |
|
2540
Spruce Power Holding Corp
SPRU
$36.6M
| $137K | ﹤0.01% |
+26,842
| New | +$109K |
|
|
SHMD
2541
SCHMID Group
SHMD
$238M
| $137K | ﹤0.01% |
+22,050
| New | +$97.1K |
|
2542
TeraWulf
WULF
$7.48B
| $137K | ﹤0.01% |
11,885
-173,308
| -94% | -$2.32M |
|
2543
InflaRx
IFRX
$243M
| $135K | ﹤0.01% |
+133,760
| New | +$166K |
|
2544
Instil Bio
TIL
$49M
| $135K | ﹤0.01% |
+12,267
| New | +$181K |
|
|
ICG
2545
Intchains Group
ICG
$49.2M
| $135K | ﹤0.01% |
75,354
+49,389
| +190% | +$76.3K |
|
2546
Candel Therapeutics
CADL
$689M
| $134K | ﹤0.01% |
+23,776
| New | +$128K |
|
2547
Full House Resorts
FLL
$83.4M
| $134K | ﹤0.01% |
51,423
+28,979
| +129% | +$77.8K |
|
2548
Laser Photonics
LASE
$48.5M
| $134K | ﹤0.01% |
+54,331
| New | +$183K |
|
2549
Data Storage Corp
DTST
$6.85M
| $134K | ﹤0.01% |
+26,147
| New | +$116K |
|
2550
BioCryst Pharmaceuticals
BCRX
$2.42B
| $133K | ﹤0.01% |
+17,111
| New | +$124K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.